On February 3, 2026, Ruchuan Gu successfully defended his half-time PhD work, an important component of The Bridge research program focused on developing cell-based therapies for injured donor organs. His work represents a significant contribution to the center’s regenerative medicine efforts, and we extend sincere thanks to all collaborators and supervisors involved in this achievement. Runchuan Gu